Mouse HCM Model Expression E99K ACTC Mutation Reproduces the Clinical HCM Phenotype

Mouse HCM Model Expression E99K ACTC Mutation Reproduces the Clinical HCM Phenotype

Bibliografiset tiedot
Päätekijät:	Song, W, Stuckey, D, Dyer, E, Wells, D, Harding, SE, Carr, C, Clarke, K, Marston, S
Aineistotyyppi:	Conference item
Julkaistu:	2009

Samankaltaisia teoksia

PHENOTYPE OF THE ACTC E99K TRANSGENIC MOUSE REPRODUCES HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS
Tekijä: Song, W, et al.
Julkaistu: (2010)

Mouse Model of Familial Hypertrophic Cardiomyopathy with E99K ACTC Mutation Recapitulates Many Features of Hypertrophic Cardiomyopathy in Patients
Tekijä: Song, W, et al.
Julkaistu: (2008)

Investigation of a mouse model of familial DCM with ACTC E361G mutation
Tekijä: Song, W, et al.
Julkaistu: (2008)

In vitro motility studies of HCM and DCM mutations in cardiac muscle actin
Tekijä: Dyer, E, et al.
Julkaistu: (2007)

Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.
Tekijä: Song, W, et al.
Julkaistu: (2011)

Autosomal dominant HCM and DCM phenotype caused by a novel mutation in phospholamban
Tekijä: Carballo, S, et al.
Julkaistu: (2004)

Evidence for haploinsufficiency as the mechanism of action of MyBP-C mutations that cause HCM
Tekijä: Carballo, S, et al.
Julkaistu: (2008)

ATTR Gene Variants in HCM
Tekijä: Anthony J. Kanelidis, MD, et al.
Julkaistu: (2024-03-01)

HCM and DCM mutations in thin filament proteins have opposite effects on in vitro motility
Tekijä: Marston, S, et al.
Julkaistu: (2002)

The HCM-associated cardiac Troponin T mutation K280N causes reduced responsiveness to protein kinase A
Tekijä: Van Der Velden, J, et al.
Julkaistu: (2012)

Functional investigation of troponin with the homozygous HCM mutation, TNNT2 K280N, obtained from an explanted heart
Tekijä: Bayliss, C, et al.
Julkaistu: (2012)

HCM2010 : highway capacity manual /
Tekijä: National Research Council (U.S.). Transportation Research Board
Julkaistu: (2010)

Sarcomeric versus Non-Sarcomeric HCM
Tekijä: Felice Borrelli, et al.
Julkaistu: (2023-06-01)

HCM and DCM mutations in thin filament proteins have opposite effects on regulation of contractility in vitro
Tekijä: Redwood, C, et al.
Julkaistu: (2003)

HCM and DCM mutations in cardiac thin filament proteins have opposite effects on the regulation of contractility in vitro
Tekijä: Redwood, C, et al.
Julkaistu: (2003)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
Tekijä: Neubauer, S, et al.
Julkaistu: (2019)

The HCM-Associated Cardiac Troponin T Mutation K280N Increases the Energetic Cost of Tension Generation in Human Cardiac Myofibrils
Tekijä: Ferrara, C, et al.
Julkaistu: (2013)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
Tekijä: Neubauer, S, et al.
Julkaistu: (2019)

Leaders’ learning orientation and the HCM-turn in call centres
Tekijä: Dorina Gnauer
Julkaistu: (2013-06-01)

Ischaemia as a cause of LVOT gradient reversal in HCM
Tekijä: Camelia Demetrescu, et al.
Julkaistu: (2017-10-01)

Firms’ satisfaction with service quality of the HCM City Tax
Tekijä: Lê Bảo Lâm, et al.
Julkaistu: (2021-03-01)

Fabry Disease Mistaken for HCM: The Diagnostic Impact of T1 Mapping
Tekijä: Stefano Censi, MD, et al.
Julkaistu: (2024-01-01)

The effect of HCM mutations in troponin T and troponin I on the calcium binding of human cardiac troponin
Tekijä: Redwood, C, et al.
Julkaistu: (2001)

MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM
Tekijä: Mengmeng Li, et al.
Julkaistu: (2018-06-01)

Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits
Tekijä: James G.W. Smith, et al.
Julkaistu: (2018-11-01)

Asymmetrically Clipped Optical Hadamard Coded Modulation (ACO-HCM)
Tekijä: Henrik Schulze, et al.
Julkaistu: (2023-01-01)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
Tekijä: Dass, S, et al.
Julkaistu: (2012)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
Tekijä: Carballo, S, et al.
Julkaistu: (2005)

Age and strain related aberrant Ca(2+) release is associated with sudden cardiac death in the ACTC E99K mouse model of hypertrophic cardiomyopathy
Tekijä: Rowlands, C, et al.
Julkaistu: (2017)

Applicability of HCM LOS criteria for Malaysian single-carriageway performance analysis
Tekijä: Md. Ithnan, Mohd. Izuddin
Julkaistu: (2007)

Applicability of HCM LOS criteria for Malaysian single-carriageway performance analysis /
Tekijä: 355159 Mohd. Izuddin Md. Ithnan, et al.
Julkaistu: (2007)

Multilevel modelling for decision support in hypertrophic cardiomyopathy in the SMASH-HCM project
Tekijä: Alpo Olavi Värri, et al.
Julkaistu: (2024-05-01)

HCM‐based indoor optical wireless communications: Timing and data recovery
Tekijä: Masoud Johar, et al.
Julkaistu: (2023-10-01)

Methodology for analysing capacity and level of service for signalized intersections (HCM 2000)
Tekijä: Nedevska Ivana, et al.
Julkaistu: (2016-01-01)

Việc làm và trẻ lang thang tại TP.HCM
Tekijä: Lê Thị Mỹ Hiền
Julkaistu: (2005-03-01)

A complex unit for a complex disease: the HCM-Family Unit
Tekijä: Olga Vriz, et al.
Julkaistu: (2021-12-01)

Maturity of IT systems supporting communication processes in HCM in a modern organization
Tekijä: Andrzej Sołtysik
Julkaistu: (2016-10-01)

Influence of Clinical Aspects and Genetic Factors on Feline HCM Severity and Development
Tekijä: Victoria Korobova, et al.
Julkaistu: (2024-05-01)

Characterisation and distribution of a cryptic Salmonella typhi plasmid pHCM2.
Tekijä: Kidgell, C, et al.
Julkaistu: (2002)

Interaction analyses elucidate the pathophysiology of HCM-causing missense mutations in cardiac myosin binding protein-C.
Tekijä: Moolman-Smook, J, et al.
Julkaistu: (2001)